Dr John Kruse
@drjohnkruse·16.8K subscribers·484 videos
Reboxetine for ADHD?
Posted
August 8, 2026
Views
132
Likes
10
Engagement
7.58%
August 8, 2026
132
10
7.58%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
1:29Now PlayingReboxetine was almost the first norepinephrine reuptake inhibitor on the market - a few years before atomoxetine/Strattera. But after provisionally approving reboxetine, the FDA rejected its use for depression. Now, almost 30 years later, the FDA has indicated that they will likely approve reboxetine for a symptom of narcolepsy - which will mean that US prescribers will be able to write for the medication for ADHD, depression, panic attacks, bulimia, or any condition they have reason to believe it works for. But the debate over whether reboxetine is any good for treating any of these is still open to debate...
#health #mentalhealth #adhd #reboxetine
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
